Elanco Saude Animal Ltda.

What Elanco Saude Animal Ltda. does

Elanco Saude Animal Ltda. is the Brazilian operating subsidiary of Elanco Animal Health Incorporated (NYSE: ELAN), a global animal health company headquartered in Indianapolis, Indiana, with origins dating to 1953 and an independent public listing since its 2019 separation from Eli Lilly. The Brazilian entity operates from a regional headquarters in São Paulo and serves the Brazil market through two horizontal product segments: farm animals (cattle, swine, poultry, and aquaculture) and companion animals (dogs and cats). Elanco's portfolio spans parasiticides, antibiotics, vaccines, monoclonal antibodies (Canine Parvovirus Monoclonal Antibody), dermatology products (Zenrelia/ilunocitinib), chronic-disease therapeutics (Bexacat, Varenzin), and novel sustainability products such as Bovaer (3-NOP), a first-in-class methane-reducing feed ingredient for dairy cattle.

Technically, the company's differentiation rests on a proprietary R&D engine plus strategic alliances with Purdue University, Colorado State University AgNext, Royal DSM, and ATHIAN, supporting both therapeutic innovation and sustainability-linked product development. Branded assets such as Credelio (lotilaner), Advantage (imidacloprid), Seresto collars, and K9 Advantix carry substantial brand equity across prescription and OTC companion-animal categories, while cattle implants, parasiticides, and vaccines anchor the livestock offering.

Commercially, Elanco Saude Animal Ltda. generates revenue through one-time product sales across both segments via a multi-channel go-to-market model: enterprise field sales to large livestock operations, authorized veterinary clinics and retailer networks for companion-animal products, regional direct platforms (Portal Agro for farm, Meu Pet and Puppy Program for pets), and channel/distributor partnerships. Pricing is quote-based and not publicly disclosed. Recent ESG credentials (Newsweek America's Greenest Companies, Mais Integridade Seal from MAPA, Investors in the Environment certifications) underscore the subsidiary's positioning within Brazil's agricultural sector.

Name

Elanco Saude Animal Ltda.

Legal name

Elanco Saude Animal Ltda.

Website

https://elanco.com.br

Company type

Public

Operating status

Operating

Headcount range

11–50 employees

Short description

Brazilian subsidiary of NYSE-listed Elanco Animal Health (ELAN), marketing and distributing pharmaceutical products, vaccines, parasiticides, and novel therapeutics for livestock and companion animals across Brazil via veterinary clinics, authorized retailers, and digital portals.

Ownership category

akta.pro rank

Product category

Animal Health Pharmaceuticals

SIC

Pharmaceutical Preparations (2834), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)

akta.pro secondary industries

Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK), Veterinary Vaccine & Biologics Distributors (HLAMAIAC), Animal Health OTC Retail (Parasite Control, Basic Care) (HLAMAIAJ)

Keywords

• Animal health pharmaceuticals
• Veterinary vaccines
• Companion animal products
• Livestock parasiticides
• Pet parasiticides

Headquarters

HQ city

Indianapolis

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations

Revenue model

1. Pharmaceutical Products for Farm Animals: Revenue from parasiticides, antibiotics, vaccines, and other pharmaceutical products for cattle, swine, poultry, and aquaculture.
2. Companion Animal Products: Revenue from flea/tick treatments (Credelio, Advantage, Seresto), dermatology products, and other pet health medications sold through veterinary clinics and retailers.
3. Vaccines: Pet health and livestock vaccines generating recurring revenue through established product lines.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

Elanco Saude Animal Ltda. develops, manufactures, and distributes a broad portfolio of animal health pharmaceutical products including parasiticides, vaccines, antibiotics, monoclonal antibodies, dermatology treatments, and feed ingredients for both farm animals (cattle, swine, poultry, aquaculture) and companion animals (dogs, cats). The company sells through veterinary clinics, authorized retailers, direct sales, and digital platforms (Portal Agro, Meu Pet, MyElanco) serving livestock farmers, pet owners, and veterinary professionals in Brazil.

Product overview

Elanco is a global animal health company providing an extensive portfolio of pharmaceutical products and digital platforms for both companion animals (pets) and farm animals (livestock). The companion animal portfolio includes well-known brands like Advantage, K9 Advantix, Seresto, Credelio, Zenrelia, and Bexacat, alongside innovative treatments like Canine Parvovirus Monoclonal Antibody. The farm animal portfolio serves cattle, swine, poultry, and aquaculture sectors with products like Bovaer for methane reduction. Elanco supports its product portfolio with digital platforms including Portal Agro for livestock farmers, Meu Pet for pet owners, MyElanco for veterinarians, and Paws for Purpose+ for shelter and community partnerships. The company operates under the 'Healthy Purpose' sustainability framework focused on healthier animals, people, planet, and enterprise.

Differentiator

Problem solved

Functional benefit

Products and services

• Portal Agro Digital portal providing comprehensive information for livestock farmers to improve animal health, well-being, and production outcomes. Serves as a Brazil-specific e-commerce platform for farm animal products.
• Meu Pet Pet owner portal containing information needed to maintain a happy and healthy pet, including product information and puppy care resources.
• Programa de Filhotes (Puppy Program) Support program for new pet owners or those considering adoption, providing guidance on pet care and puppy health.
• Advantage (product line) Non-prescription flea and tick prevention products for dogs and cats, including Advantage, Advantage II, Advantage XD, Advantage Defend, and Advantage Defense variants.
• K9 Advantix (product line) Non-prescription flea, tick, and mosquito prevention products for dogs, including K9 Advantix, K9 Advantix II, and K9 Advantix Defend variants.
• Seresto Flea and tick collar providing long-lasting protection for dogs and cats.
• Cheristin Non-prescription flea prevention product for cats.
• Advantus Non-prescription flea treatment product for dogs.
• Interceptor Plus Prescription heartworm and intestinal parasite prevention for dogs.
• Bexacat FDA-approved prescription product for feline diabetes management.
• Credelio (product line) Oral flea and tick protection for dogs and cats, including Credelio Quattro (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets).
• Zenrelia (Ilunocitinib) FDA-approved ilunocitinib tablets for canine dermatology treatment addressing itch in dogs.
• Elura/Elurat (Capromorelin) Capromorelin oral solution for cats, FDA-approved for appetite stimulation.
• Zorbium FDA-approved transdermal solution for cats.
• Canine Parvovirus Monoclonal Antibody (CPMA) Breakthrough monoclonal antibody treatment for canine parvovirus, significantly improving puppy survival rates.
• Trucan Ultra CIV H3N2/H3N8 USDA-approved H3N2/H3N8 canine influenza vaccine providing high standard respiratory protection.
• Varenzin-CA1 (Molidustat) Varenzin-CA1 molidustat oral suspension for cats with anemia due to chronic kidney disease.
• Farm Animal Products Portfolio Comprehensive portfolio for livestock including cattle, swine, poultry, and aquaculture, including parasiticides, vaccines, antibiotics, cattle implants, and performance products.
• Bovaer (3-NOP) First-in-class methane-reducing feed ingredient for dairy cattle, FDA reviewed, targeting 40-50% enteric methane emissions reduction.
• PenPoint Feedyard management platform with enhanced offerings for feedyards.
• Paws for Purpose+ Integrated platform bringing together affordable products, shelter support, community partnerships, and employee giving to increase access to pet health products and care.
• MyElanco Platform for veterinarians to access information for treating and protecting patients with resources to optimize their business.

Quantifiable outcome

• More than 1.4 million households and 293 communities helped become food-secure
• +2 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eight partnerships are on record, tiered core, strategic and minor.

• SAP Business Network (formerly Ariba)coreTechnology or IntegrationElanco uses SAP Business Network for streamlined procurement and accounts payable processes, enabling digital transaction management with suppliers across the globe following deployment of SAP ERP platform in 2021.
• Pharmaceutical Supply Chain Initiative (PSCI)coreStrategic or Co-development PartnerElanco is a member of PSCI and requires key suppliers to meet PSCI principles including potential periodic surveys and on-site assessments for workplace compliance.
• Purdue University and Purdue Research FoundationstrategicStrategic or Co-development PartnerStrategic alliance announced to advance innovation in animal health through research collaboration and technology development.
• Colorado State University AgNextstrategicStrategic or Co-development PartnerStrategic alliance to advance sustainable livestock production and environmental stewardship in agriculture.
• Royal DSMstrategicStrategic or Co-development PartnerStrategic alliance focused on developing and commercializing innovative animal health and nutrition solutions.
• ATHIANstrategicStrategic or Co-development PartnerCollaboration to transform food production through methane reduction, supporting climate-neutral farming initiatives.
• MedgeneminorChannel Partner/ Reseller/ DistributorAgreement to commercialize HPAI (Highly Pathogenic Avian Influenza) vaccine for dairy cattle.
• Animal Shelters and Rescue OrganizationsstrategicGTM or Marketing PartnerPaws for Purpose program partners with shelters and community clinics across the US to provide vaccines, preventative care, treatment, and support services to pets and families.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Regional players

• Ourofino Saúde Animal: Brazil's largest domestic animal health company, manufacturing pharmaceuticals, vaccines, and parasiticides for livestock and companion animals. Direct competitor within Brazil and a regional counterpart to Elanco's local subsidiary.
• Agener União Saúde Animal: Brazilian animal health pharmaceutical company offering therapeutics and parasiticides for companion and farm animals. Regional competitor serving the same Brazilian veterinary and farm channels.

Direct peers

• Virbac: Global animal health pharmaceutical company with strong companion animal and livestock presence. Comparable business model of selling branded parasiticides, vaccines, and specialty therapeutics to veterinary channels.
• Vetoquinol: European animal health pharmaceutical company focused on companion and farm animals. Comparable in therapeutic categories and channel mix (veterinary and farm distribution) to Elanco's Brazilian operations.
• Dechra Pharmaceuticals: Specialty animal health pharmaceutical company focused on companion animals (dogs, cats, horses). Comparable as a branded prescription therapeutics provider serving veterinary clinics, similar to Elanco's specialty pet portfolio.
• Zoetis: World's largest pure-play animal health company. Directly comparable as a developer and marketer of pharmaceuticals, vaccines, parasiticides, and diagnostics across both companion and livestock animals, including in Brazil.
• MSD Animal Health: Animal health division of Merck & Co. Offers a similar broad portfolio of pharmaceuticals, vaccines, and parasiticides for companion and farm animals, with established operations in Brazil.
• Phibro Animal Health: US-listed animal health and nutrition company offering parasiticides, vaccines, and nutritional specialties for livestock. Comparable as a developer/marketer of livestock-focused animal health products.
• Ceva Santé Animale: France-based global animal health company covering pharmaceuticals, vaccines, and farm-animal reproduction. Directly comparable as a multi-species animal health pharma peer with active presence in Brazil.
• Boehringer Ingelheim Animal Health: Top global animal health player specializing in vaccines and therapeutics for livestock and companion animals. Direct competitor in the same therapeutic categories Elanco competes in across Brazil.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UC46iclQT-GBWwsWHT5goreg
• LinkedInlinkedin.com/company/elanco-saude-animal-ltda.
• Instagraminstagram.com/elancoagrobr

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elanco Saude Animal Ltda.